Table of contents

Review articles

• The biosimilar approval process: how different is it? (1 November, 2017) Free

  John Isaacs, João Gonçalves, Robert Strohal, Gilberto Castañeda-Hernández, Valderilio Azevedo, Thomas Dörner, Iain McInnes
• Biosimilars already approved and in development (1 November, 2017) Free

  Thomas Dörner, John Isaacs, João Gonçalves, Valderilio Azevedo, Gilberto Castañeda-Hernández, Robert Strohal, Iain McInnes
• Biosimilars: considerations for clinical practice (1 November, 2017) Free

  Valderilio Azevedo, Thomas Dörner, Robert Strohal, John Isaacs, Gilberto Castañeda-Hernández, João Gonçalves, Iain McInnes
• Considering biosimilar policy (1 November, 2017) Free

  Gilberto Castañeda-Hernández, Robert Strohal, João Gonçalves, Thomas Dörner, Valderilio Azevedo, John Isaacs, Iain McInnes